Wave & Frequency Devices

From Royal Rife to AI-Personalized Medicine: An Evidence-Based Guide to the devices that claim to heal with electromagnetic waves, frequencies, and information fields.

Historical Timeline

How fringe science, military research, and German naturopathy converged into a $2B+ global industry.

1930s

Royal Raymond Rife

Proposed Mortal Oscillatory Rate theory — specific frequencies destroy pathogens. Suppressed by AMA/ACS, but legacy survives in modern Rife machines.

1977

MORA Therapy (Germany)

Franz Morell + Erich Rasche developed MORA therapy — capturing the body's electromagnetic oscillations and returning corrected signals. Bioresonance was born.

1970–80s

SCENAR (Soviet Space Medicine)

Self-Controlled Energo Neuro Adaptive Regulation. Skin impedance measurement + neurostimulation. Approved by USSR Health Ministry in 1990.

1990s–2000s

Metatron, TimeWaver, Healy

NLS (Nonlinear Analysis Systems), information field analysis, and smartphone-connected wearables emerge. Quantum branding meets MLM distribution.

2010s–Now

FDA Approvals & Sports Medicine

PEMF devices gain FDA 510(k) clearance. FSM adopted by professional sports teams. Meta-analyses begin establishing evidence base.

Evidence Rating System

Established

Promising

Unproven

No Scientific Basis

Device Category Overview

Category	Evidence Level	Key Device	Regulatory Status
A — PEMF	Established	BEMER	FDA Class II 510(k)
B — Bioresonance	Promising	BICOM optima	EU CE Class IIa
C — FSM	Promising	Precision Distributing FSM	FDA (as TENS)
D — SCENAR	Promising	RITM SCENAR Pro	Russia: Medical Device / Australia: TGA Class IIa
E — Sound-Based	Promising	Binaural Beat Devices	Consumer electronics
F — Rife Machines	Unproven	Spooky2	None
G — Radionics	Unproven	SE-5 1000	None
H — Quantum/MLM	No Scientific Basis	Healy	FDA Class II (TENS only); DSSRC warnings

Quick-reference overview of all device categories covered in this guide. See detailed sections below for full analysis.

Established

A — PEMF (Pulsed Electromagnetic Field)

The most evidence-backed category. Pulsed magnetic fields stimulate cellular repair, reduce inflammation, and accelerate bone healing. Clear biophysical mechanism: induced electric fields trigger intracellular calcium signaling and nitric oxide production.

Meta-analysis of 14 RCTs (618 patients): chronic low back pain SMD = −1.01, P < 0.001. Market: $520M (2023) → $780M (2030), CAGR 6.0%

BEMER

Liechtenstein

FDA Class II 510(k)

Patented PEMF signal targeting microcirculation. Published data on blood flow improvement. Used by NASA for astronaut recovery research.

iMRS Prime

Switzerland

Partial FDA clearance

Whole-body mat + pillow applicators. Schumann resonance frequencies (0.5–15 Hz). Pain and fatigue recovery focus.

FlexPulse

Canada$600–900

Partial FDA clearance

Portable wearable PEMF. Published studies on nerve regeneration and chronic pain. Small form factor for targeted application.

Promising

B — Bioresonance

Theory: the body emits electromagnetic oscillations; disease produces 'pathological' oscillations that can be inverted and returned to restore health. Popular in German-speaking Europe. Cochrane reviews conclude 'no better than placebo' for most indications.

BICOM optima

Regumed, Germany$15,000–30,000

EU CE Class IIa

Flagship bioresonance device. Claims to treat allergies, autoimmune conditions, and chronic pain. Manufacturer-funded studies only.

MORA Nova

Med-Tronik, Germany

EU CE

Direct descendant of the original MORA therapy. Used for chronic conditions and depression. Large practitioner base in Germany and Austria.

Rayocomp PS 10

Rayonex, Germany

EU CE Class IIa

Unique in having a double-blind RCT for cervical spine syndrome showing positive results — rare for bioresonance. Based on Paul Schmidt's frequency model.

Promising

C — FSM (Frequency Specific Microcurrent)

Developed by Carolyn McMakin. Uses paired frequencies (tissue + condition) at sub-sensory microcurrent levels (< 1 mA). FDA approved as a TENS device. Gaining traction in sports medicine and pain management.

Objective data: IL-1, IL-6, TNF-α, Substance P reduction in fibromyalgia patients. Professional sports teams (NFL, NBA) actively using.

Precision Distributing FSM

USA

FDA (as TENS)

McMakin's original dual-channel microcurrent device. Two-frequency protocol: Channel A = tissue type, Channel B = condition. Used with conductive graphite gloves.

Promising

D — SCENAR

Self-Controlled Energo Neuro Adaptive Regulation. Developed for Soviet space program where pharmaceutical medicine was impractical. Measures skin impedance in real-time and adjusts electrical stimulation accordingly — a biofeedback loop.

RITM SCENAR Pro

Russia/Australia$3,000–7,000

Russia: Medical Device. Australia: TGA Class IIa

Handheld device with real-time skin impedance feedback. Adjusts output waveform based on tissue response. 35+ years of Russian clinical use data.

Promising

E — Sound-Based Devices

Devices that use audible sound, infrasound, or cymatics principles for therapeutic purposes. Evidence ranges from solid neuroscience (binaural beats) to speculative cymatics applications.

Eema Sound / OTOtron

Japan

Not classified as medical device

Based on cymatics / Manners principles. Claims to adjust chakras through specific sound frequencies. Popular in Japanese alternative medicine market.

Binaural Beat Devices

Various

Consumer electronics

Headphones delivering two slightly different frequencies to each ear. The perceived 'beat' frequency entrains brainwaves. Meta-analysis effect size g = 0.45 for anxiety.

Unproven

F — Rife Machines

Based on Royal Rife's 1930s theory that specific frequencies can destroy pathogens. No peer-reviewed evidence supports pathogen destruction claims. FDA has prosecuted manufacturers for making medical claims.

Spooky2

China$200–2,000

None

World's largest open-source frequency database (40,000+ programs). Remote, contact, plasma, and scalar modes. Massive user community.

TrueRife

USA$3,000–8,000

None (experimental)

Uses plasma bulb (argon/neon gas tube) technology to deliver frequencies. Claims broader spectrum delivery than electrical contact methods.

Unproven

G — Radionics

Based on the concept of 'subtle information fields' or 'morphic resonance.' Devices claim to read and broadcast healing patterns at a distance. Depends entirely on metaphysical claims that cannot be falsified.

SE-5 1000

USA$2,500–5,000

None

Digital radionic instrument. 'Intrinsic Data Field' analysis. Uses scalar technology claims. Small but dedicated user base since 1986.

Inergetix CoRe

Germany/Portugal$10,000+

None

Holographic resonance system. Software-based analysis claiming to identify energetic imbalances. Practitioner-only distribution.

No Scientific Basis

H — Quantum/MLM Devices

Devices marketed with quantum physics terminology but lacking any quantum mechanical mechanism. Often distributed through multi-level marketing. Multiple regulatory warnings issued.

Metatron (NLS)

Russia$10,000+

None internationally

Nonlinear Analysis System. Claims to read entropy of organs via headphones on 'trigger points.' Pineal gland entropy reading advertised. No peer-reviewed validation.

TimeWaver

Germany$20,000–50,000

None for medical use

Information Field analysis system. Claims to analyze 'quantum field' of the body. Creator Marcus Schmieke describes it as consciousness technology. Used by some clinics in Europe.

Healy

Germany (TimeWaver spinoff)$500–4,000

FDA Class II (TENS only). DSSRC warnings for health claims

TimeWaver mini + smartphone app. 2M+ units sold via MLM. 'Individualized Microcurrent Frequency' programs. FDA cleared only as TENS — not for any of its advertised uses. DSSRC found health claims unsubstantiated.

The day science begins to study non-physical phenomena, it will make more progress in one decade than in all the previous centuries of its existence.

— Nikola Tesla

Regulatory Landscape

The same device can be a registered medical device in one country and an illegal product in another.

Region	Regulatory Status
USA (FDA)	510(k) clearance for TENS and PEMF devices only. Strict enforcement against unsubstantiated medical claims. Healy cleared only as TENS.
EU (MDR)	BICOM and Rayocomp hold CE Class IIa certification under Medical Device Regulation. Stricter than previous MDD framework.
Russia	SCENAR officially approved as medical device. Bioresonance used for autism treatment nationally. Most permissive regulatory environment.
Japan	Most wave/frequency devices NOT approved as medical devices. Sold as 'health goods' (健康器具) in a regulatory gray zone. PMDA has not evaluated most claims.
Australia (TGA)	SCENAR registered as Class IIa medical device. Active crackdown on non-compliant advertising for alternative devices.

Frontier Science

Consciousness Research Connection

Several wave device manufacturers invoke consciousness research to support their claims. Here is what the actual research shows — fascinating, but far from proving that intention can heal through electronic devices.

PEAR Lab (Princeton, 1979–2007)

Princeton Engineering Anomalies Research. 12 years of Random Event Generator (REG) experiments, 1,000+ trials. Found statistically significant (but tiny) effects of human intention on electronic randomness. Effect size: ~1 bit per 10,000.

GCP (Global Consciousness Project)

Roger Nelson, Princeton. Network of 70+ REG devices worldwide. Reported non-random synchronicity during major events (9/11, meditation gatherings). Criticism: post-hoc pattern matching and flexible analysis choices.

HeartMath — Global Coherence Initiative

Studies on heart's magnetic field affecting others at close range. Schumann resonance (0.32–36 Hz) monitoring network. Hypothesis: human cardiovascular rhythm (0.1 Hz) synchronizes with Earth's geomagnetic field. Peer-reviewed publications exist, but causal link remains speculative.

Protocol Mapping: It’s Not Just the Frequency

Key insight: "What Hz for what" is NOT a simple question. The full protocol — frequency + intensity + waveform + duty cycle + duration + total sessions — determines the therapeutic effect. Two devices at the same frequency can produce opposite outcomes if other parameters differ.

PEMF Detailed Protocols

Target	Frequency	Intensity	Session	Duration	Evidence
🟡 Knee OA (pain)	1–3,000 Hz (diverse across RCTs)	0.105 mT – 105 mT	10–60 min/day to 12 h/day	2–6 weeks	Meta-analysis: short-term pain improvement. Protocol heterogeneity limits strong conclusions.
🟢 Spinal fusion adjunct	Product-specific (proprietary)	Prescription	Prescription	Prescription	RCT + FDA PMA approval. SpinalStim / Cervical-Stim devices.
🟡 Chronic low back pain	Various (1–100 Hz common)	0.1–10 mT typical	15–40 min/day	2–8 weeks	Meta-analysis of 14 RCTs (618 patients): SMD = −1.01, P < 0.001. Significant but short-term.

LIPUS (Low-Intensity Pulsed Ultrasound) Protocols

Target	Frequency	Intensity	Session	Evidence
🟢 Nonunion fracture healing	1.5 MHz typical	30 mW/cm² (SATA)	20 min/day	RCT + FDA PMA (86% healing rate). Exogen 2000+ / SAFHS devices.
🟡 Fresh fracture acceleration	1.5 MHz	30 mW/cm² (SATA)	20 min/day	Mixed results in recent meta-analyses. Some show 38% reduction in healing time, others no significant benefit.

40 Hz Gamma Entrainment Protocols

Target	Frequency	Intensity	Session	Evidence
🟡 Mild Alzheimer's disease	40 Hz (light + sound entrainment)	Non-invasive sensory stimulation	1 h/day × 3 months	Single-blind pilot RCT (small sample). MIT research: activates glymphatic system, reduces amyloid/tau pathology in mouse models.
🟡 Cognitive enhancement (healthy)	40 Hz (audio/visual)	Non-invasive	30–60 min/day	Preliminary studies show improved attention and memory consolidation. No large-scale RCTs yet.

Regulatory

FDA-Approved Devices (PMA & 510(k))

These devices have passed the FDA's most rigorous review pathways. PMA (Pre-Market Approval) requires clinical trial evidence. 510(k) requires demonstration of substantial equivalence to a predicate device. This is the gold standard for regulatory legitimacy.

Modality	Device	Pathway	Approved Indication
🟢 LIPUS	Exogen 2000+ / SAFHS	PMA	Established nonunion fracture healing
🟢 ESWT	OssaTron	PMA	Chronic plantar fasciitis / lateral epicondylitis
🟢 PEMF	SpinalStim	PMA	Spinal fusion adjunct (lumbar)
🟢 PEMF	Cervical-Stim	PMA	High-risk cervical fusion adjunct
🟡 PBM / LLLT	Various (class-level clearance)	510(k)	Pain adjunct / temporary local blood flow increase
🟡 TENS / Microcurrent	Various (incl. Healy as TENS only)	510(k)	Symptomatic pain relief only

Japan / PMDA

Japanese Regulatory Framework (PMDA)

Critical: In Japan, the boundary between a "medical device" and "miscellaneous goods" is NOT the device itself, but what you CLAIM. The same physical device can be sold as "miscellaneous goods" (雑貨) if no therapeutic claims are made, or require PMDA approval as a "medical device" (医療機器) if therapeutic claims appear in advertising. This is why many wave/frequency devices operate in Japan as "health goods" (健康器具) — they avoid PMDA jurisdiction by avoiding medical claims in marketing.

Modality	PMDA Class	Note
Home low-frequency therapy device	Class II	General registration. Commonly sold OTC.
Home electric massager	Class II	Vibration/EMS devices for muscle relaxation.
Home permanent magnet therapy device	Class II	Static magnetic field devices (e.g., magnetic necklaces).
Ultrasound fracture treatment (LIPUS)	Class II	Medical prescription. Insurance-covered for fractures.
Extracorporeal shock wave (ESWT)	Class III	Higher risk classification. Hospital-use only.
Semiconductor laser therapy device	Class III	Requires specific safety testing and clinical evidence.

Microcurrent for temporary pain relief (TENS function only)

DANGEROUS (high risk)

"Quantum frequency healing" / "Analyzes your quantum field" / Any specific disease claim

If you want to find the secrets of the universe, think in terms of energy, frequency and vibration.

— Nikola Tesla

Established Mechanism

Mechanotransduction: How Vibration Becomes Biology

This is the real science behind why some frequency/vibration therapies work. It's not quantum — it's mechanics at the cellular level. 2024 reviews have mapped the complete signaling cascade.

The Signaling Cascade

Physical Input

Audible sound waves (AAW) and low-frequency vibration (LVS) propagate through extracellular matrix (ECM).

Mechanosensors

Integrins, ion channels (Piezo1/2, TRPV), and primary cilia detect mechanical deformation at the cell surface.

Cytoskeletal Transmission

Physical forces transmit through actin filaments and the LINC (Linker of Nucleoskeleton and Cytoskeleton) complex to the nucleus.

Nuclear Response

YAP/TAZ transcriptional co-activators are activated. Chromatin structural changes occur. Direct gene expression control is initiated.

Biological Outcomes

Stem cell differentiation; collagen/ECM production for tissue repair; at specific frequencies (e.g., 20 Hz), tumor cell metabolic and oxidative stress responses.

This is established cell biology — no quantum mechanics required. When a PEMF or vibro-acoustic device produces measurable results, this pathway is almost certainly the mechanism. This is why protocol parameters (frequency, intensity, duration) matter so much: different parameters activate different mechanosensors and downstream pathways.

Boundary Patrol

Quantum Biology: What CAN and CANNOT Be Said

The word "quantum" is the most abused term in wellness marketing. Real quantum biology exists — and it's fascinating. But it has almost nothing to do with consumer "quantum" devices. Here is a rigorous boundary.

Microtubules & consciousness

CAN say (defensible)

Microtubules may be anesthesia targets; collective optical responses have been observed in laboratory settings.

CANNOT say (indefensible)

Consciousness is causally explained by quantum computation in microtubules (Orch-OR remains speculative).

PEMF / Vibro-acoustic therapy

CAN say (defensible)

These work via mechanotransduction — a well-established biochemical pathway involving integrins, ion channels, and cytoskeletal signaling.

CANNOT say (indefensible)

These are 'quantum healing' or 'quantum vibration therapy.' No quantum mechanical mechanism is involved.

Water memory / Emoto

CAN say (defensible)

Water forms crystalline structures when frozen. Environmental conditions affect crystal morphology.

CANNOT say (indefensible)

Human intention, words, or music causally change water's molecular structure. No reproducible evidence exists.

Quantum biology (photosynthesis, etc.)

CAN say (defensible)

Quantum coherence is observed in photosynthetic complexes and avian magnetoreception. These are active research fields.

CANNOT say (indefensible)

Therefore, any device using the word 'quantum' has a scientific basis. Real quantum biology is unrelated to consumer 'quantum' devices.

🔴

Solfeggio 528 Hz: The Verdict

"DNA repair" claim

NO robust clinical evidence supports the claim that 528 Hz sound waves repair DNA. The single most-cited study (Rein, 1988) has never been independently replicated, used non-standard methodology, and is published in a non-indexed journal. Subsequent studies showing "reduced anxiety" or "mood improvement" have small sample sizes, no blinding, and do not support DNA-level claims.

Maximum defensible claim

"Sound for mood change and relaxation." Music at any pleasant frequency can reduce cortisol and improve mood. There is nothing unique about 528 Hz compared to other frequencies in this regard.

This matters for MEGURI's credibility: In a field where many organizations promote unsubstantiated frequency claims, being honest about 528 Hz — that it has no special healing power beyond pleasant sound — establishes trust. We do not need to debunk the subjective experience of people who enjoy this frequency. We simply refuse to attach false scientific claims to it.

Evidence Summary

Top 3 Scientifically Promising

PEMF — Established. Multiple meta-analyses + FDA approvals. Clear biophysical mechanism (induced electric fields → calcium signaling).
FSM — Promising. Objective cytokine reduction data (IL-1, IL-6, TNF-α). Sports medicine adoption growing.
SCENAR — Promising. Russia & Australia medical device registration. Real-time biofeedback mechanism is plausible.

Large Market, Weak Evidence

Healy — 2M+ units sold via MLM. Zero scientific basis for 'quantum frequency' claims. FDA/DSSRC warnings issued.
Emoto HADO water memory — Explicitly denied by peer-reviewed science. No reproducible evidence for water 'memory' or crystal formation by intention.
Radionics devices — Entirely dependent on unfalsifiable metaphysical claims. No plausible mechanism. Expensive ($2,500–$10,000+).

For the science of sound and acoustic phenomena (cymatics, acoustic levitation, binaural beats), see our companion article:

Sound, Frequency & Consciousness →

Sources

Andrade, R. et al. (2016). "Pulsed electromagnetic field therapy effectiveness in low back pain: a systematic review." BMC Musculoskeletal Disorders, 17(1), 1-8.
Multanen, J. et al. (2018). "Effect of PEMF on knee osteoarthritis." Bioelectromagnetics, 39(8), 636-646.
McMakin, C. (2011). "Frequency Specific Microcurrent in Pain Management." Elsevier, 1st ed.
McMakin, C. et al. (2005). "Cytokine changes with microcurrent treatment of fibromyalgia." JBMT, 9(3), 169-176.
Tarasov, A.N. et al. (2001). "SCENAR therapy in clinical practice." Russian Ministry of Health report.
Cochrane Database (2019). "Bioresonance for the treatment of allergies and other conditions: a systematic review."
Rayonex GmbH (2013). "Double-blind RCT of bioresonance in cervical spine syndrome." Internal publication (EU CE dossier).
FDA Warning Letter to Healy World GmbH (2021). Unsubstantiated health claims for microcurrent device.
DSSRC (2022). "National Advertising Division decision on Healy World." NAD case report.
Jahn, R. & Dunne, B. (2005). "The PEAR Proposition." J. of Scientific Exploration, 19(2), 195-245.
Nelson, R. et al. (2002). "Correlations of continuous random data with major world events." Foundations of Physics Letters, 15(6), 537-550.
McCraty, R. et al. (2017). "Synchronization of human autonomic nervous system rhythms with geomagnetic activity." Int. J. of Environmental Research and Public Health, 14(7), 770.
Garcia-Argibay, M. et al. (2019). "Efficacy of binaural auditory beats in cognition, anxiety, and pain perception." Psychological Research, 83(2), 357-372.
Morell, F. (1977). "MORA-Therapie: Patienteneigene und Farboszillationen." Haug Verlag.
Rife, R.R. (1953). "History of the Development of a Successful Treatment for Cancer." Unpublished manuscript.
Grand View Research (2024). "Pulsed Electromagnetic Field Therapy Devices Market Size Report." GVR-4-68038-0150.
Cadossi, R. et al. (2020). "Pulsed electromagnetic field stimulation of bone healing and joint preservation." Bioelectromagnetics, 41(4), 265-274.
Heckman, J.D. et al. (1994). "Acceleration of tibial fracture-healing by non-invasive, low-intensity pulsed ultrasound." JBJS, 76(1), 26-34.
Markov, M.S. (2007). "Pulsed electromagnetic field therapy history, state of the art and future." Environmentalist, 27(4), 465-475.
Iaccarino, H.F. et al. (2016). "Gamma frequency entrainment attenuates amyloid load and modifies microglia." Nature, 540, 230-235.
Chan, D. et al. (2021). "Gamma frequency sensory stimulation in mild probable AD dementia patients: results of feasibility study." PLoS ONE, 16(12), e0278412.
FDA PMA Database. "P900009: OssaTron Shock Wave Therapy Device." Accessed 2024.
FDA PMA Database. "P850007 S27: SpinalStim Bone Growth Stimulator." Accessed 2024.
PMDA (2023). "Medical Device Classification Guidelines." Pharmaceutical and Medical Devices Agency, Japan.
Nikukar, H. et al. (2013). "Osteogenesis of mesenchymal stem cells by nanoscale mechanotransduction." ACS Nano, 7(3), 2758-2767.
Rubin, C. et al. (2004). "Prevention of postmenopausal bone loss by a low-magnitude, high-frequency mechanical stimulation." JBMR, 19(3), 343-351.
Penrose, R. & Hameroff, S. (2014). "Consciousness in the universe: a review of the Orch OR theory." Physics of Life Reviews, 11(1), 39-78.
Oelze, M.L. & Mamou, J. (2016). "Review of quantitative ultrasound: Envelope statistics and backscatter coefficient imaging and contributions to diagnostic ultrasound." IEEE TUFFC, 63(2), 336-351.
Luo, J. et al. (2024). "Mechanotransduction in tissue engineering and regenerative medicine (review)." Frontiers in Bioengineering and Biotechnology, 12, 1339066.

View complete Source Map →